Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2005
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005049573A1 Phenyl derivatives as ppar agonists
06/02/2005WO2005049572A1 Benzannelated compounds as ppar activators
06/02/2005WO2005005606A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
06/02/2005WO2005005380A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
06/02/2005US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
06/02/2005US20050119290 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
06/02/2005US20050119273 Small molecule toll-like receptor (TLR) antagonists
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119269 Heterocyclic compounds and methods of making and using thereof
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119255 Phenylpyrimidine amines as ige inhibitors
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
06/02/2005CA2545484A1 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin
06/02/2005CA2545196A1 Pyrazolopyrimidines
06/02/2005CA2543247A1 Benzannelated compounds as ppar activators
06/01/2005EP1535911A1 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535630A1 Preventive for the onset of diabetes
06/01/2005EP1534691A1 2,4- diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors
06/01/2005EP1534690A1 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
06/01/2005EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
06/01/2005EP1534688A1 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534679A2 Inhibitors of post-amadori advanced glycation end products
06/01/2005EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
06/01/2005EP1351959B1 Novel pleuromutilin derivatives
06/01/2005EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
06/01/2005EP1265874B1 Method for the production of (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-ylpropoxy)-6-nitroquinazolin-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-aminoquinazolin-4-yl]-amine
06/01/2005EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
06/01/2005EP1165524B1 Method of producing thiobarbituric acid derivatives
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
06/01/2005CN1622807A Phenylpyrimidine amines as IgE inhibitors
06/01/2005CN1204137C Uracil compound and its appliance
06/01/2005CN1204127C 2, 6-dipirimioxy benzoxy quaternary ammonium salt compound
05/2005
05/31/2005US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis
05/31/2005US6900319 Carbo- and heterocyclic amidines
05/31/2005US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor
05/31/2005US6900316 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
05/31/2005US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
05/31/2005US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer
05/31/2005US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900210 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
05/31/2005US6899992 Imaging, development lithography printing plates
05/31/2005US6899806 C-nitrosoaniline compounds and their blends as polymerization inhibitors
05/26/2005WO2005047524A2 Compositions and methods for inducing cell dedifferentiation
05/26/2005WO2005046698A1 Fused heterocyclic compounds
05/26/2005WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/26/2005WO2005046604A2 Heteroaryl-hydrazone compounds
05/26/2005WO2005030782A3 Carbene ligands and their use
05/26/2005WO2005002582A3 Trp-p8 active compounds and therapeutic treatment methods
05/26/2005WO2004108664A3 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
05/26/2005US20050113595 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113396 Na+/H++exchanger-3 (NHE-3) inhibitors; antiischemic agents
05/26/2005US20050113393 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine
05/26/2005US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample
05/26/2005US20050112693 Screening, biosynthesis of peptides
05/26/2005US20050112407 Organic electroluminescent device
05/26/2005CA2545340A1 Fused heterocyclic compounds
05/26/2005CA2545259A1 Heteroaryl-hydrazone compounds
05/26/2005CA2544247A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
05/26/2005CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/26/2005CA2534342A1 Amino acid prodrugs
05/25/2005EP1533304A1 Amide derivative
05/25/2005EP1533303A1 Substituted Aminosalicylacid Amides ( intermediates )
05/25/2005EP1533292A1 Dibenzylamine compound and medicinal use thereof
05/25/2005EP1532152A1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl]-pyrazol- 1,5-alpha]-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
05/25/2005EP1532121A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
05/25/2005EP1531821A2 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
05/25/2005CN1620450A Quinazoline(di) ones for invertebrate pest control
05/25/2005CN1620421A Substituted alkyl diamine
05/25/2005CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use
05/25/2005CN1618792A Method of producing methoxyimino acetic amide
05/25/2005CN1203065C Non-yellowing para-tertiaryl-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers
05/25/2005CN1203064C Amino-sulfonylurea compound with herbicide activity
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6897214 Quinazoline derivatives
05/24/2005US6897213 Heterocycles as cholecystokinin (CCK) ligands
05/24/2005US6897210 Anticancer agents; antiarthritic agents
05/19/2005WO2005044785A1 Aralkyl amines as cannabinoid receptor modulators
05/19/2005WO2005035500A3 Therapeutic agents useful for treating pain
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005WO2004092123A3 Inhibitors of fungal invasion
05/19/2005WO2004064718A3 Irreversible inhibitors of egf receptor tyrosine kinases and uses thereof
05/19/2005WO2004039786A8 Electroluminescent device
05/19/2005WO2003049678A3 Mitotic kinesin inhibitors
05/19/2005US20050107609 Pyrimidine compounds and their use
05/19/2005US20050107414 enzyme inhibitors such as N-(4-{4-[5-(2-Ethoxy-ethyl)-2,4,6-trioxo-hexahydro-pyrimidin-5-yloxy]-phenoxy}-benzyl)-acetamide, used for treating inflammation, cancers and other disorders
05/19/2005US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases
05/19/2005US20050107409 drugs such as 3-{[7-(2,5-dihydropyrrol-1-yl-carbonyl)-quinazolin-4-yl]aminomethyl}-4-hydroxy-benzamidine, used as anticoagulants
05/19/2005US20050107404 Mitotic kinesin inhibitors
05/19/2005US20050107385 Aromatic prodrugs of propofol, compositions and uses thereof
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 427